Your browser doesn't support javascript.
loading
Lessons learned from drug trials in neurofibromatosis: A systematic review.
Dhaenens, Britt A E; Ferner, Rosalie E; Evans, D Gareth; Heimann, Guenter; Potratz, Cornelia; van de Ketterij, Edwin; Kaindl, Angela M; Hissink, Geesje; Carton, Charlotte; Bakker, Annette; Nievo, Marco; Legius, Eric; Oostenbrink, Rianne.
Afiliación
  • Dhaenens BAE; Department of General Paediatrics, Sophia's Children's Hospital, Rotterdam, the Netherlands; ENCORE, Erasmus MC Rotterdam, the Netherlands.
  • Ferner RE; Department of Neurology, Guy's and St. Thomas' NHS Foundation Trust London, UK.
  • Evans DG; Centre for Genomic Medicine, Division of Evolution and Genomic Sciences, University of Manchester, St Mary's Hospital, Manchester, UK.
  • Heimann G; Biostatistics & Pharmacometrics, Novartis Pharma AG, Basel, Switzerland.
  • Potratz C; Department of Paediatric Neurology, Charité Universitätsmedizin Berlin, Germany.
  • van de Ketterij E; European Infrastructure for Translational Medicine (EATRIS), Amsterdam, Netherlands.
  • Kaindl AM; Department of Paediatric Neurology, Charité Universitätsmedizin Berlin, Germany; Institute of Cell- and Neurobiology, Charité Universitätsmedizin Berlin, Germany; Center for Chronically Sick Children (Sozialpädiatrisches Zentrum, SPZ), Charité Universitätsmedizin Berlin, Germany.
  • Hissink G; Department of General Paediatrics, Sophia's Children's Hospital, Rotterdam, the Netherlands.
  • Carton C; Department of Human Genetics, KU Leuven, Belgium.
  • Bakker A; Children's Tumor Foundation, New York, USA.
  • Nievo M; Children's Tumor Foundation, New York, USA.
  • Legius E; Department of Clinical Genetics, UZ Leuven, Belgium; Full Member of the European Reference Network on Genetic Tumour Risk Syndromes, (ERN GENTURIS)-Project ID No 739547, UK.
  • Oostenbrink R; Department of General Paediatrics, Sophia's Children's Hospital, Rotterdam, the Netherlands; ENCORE, Erasmus MC Rotterdam, the Netherlands; Full Member of the European Reference Network on Genetic Tumour Risk Syndromes, (ERN GENTURIS)-Project ID No 739547, UK. Electronic address: R.Oostenbrink@erasm
Eur J Med Genet ; 64(9): 104281, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34237445
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Neurofibromatosis Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: Eur J Med Genet Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Neurofibromatosis Tipo de estudio: Guideline / Prognostic_studies / Systematic_reviews Idioma: En Revista: Eur J Med Genet Asunto de la revista: GENETICA MEDICA Año: 2021 Tipo del documento: Article